Why Rayonier Advanced Materials Shares Are Surging Today
RBC Capital analyst Paul C. Quinn has upgraded the ratings on Rayonier Advanced Materials Inc (NYSE:RYAM) to Outperform from Sector Perform and…
5 Reasons Bank Of America Upgraded Expensify To Buy
Expensify Inc. (NASDAQ: EXFY) is well positioned to evolve into a leading expense management solution for small and medium businesses, according to BofA Securities.
New Street Research Upgrades Nu Holdings to Buy, Announces $7 Price Target
New Street Research analyst Soomit Datta upgrades Nu Holdings (NYSE:NU) from Neutral to Buy and announces $7 price target.
Fox Advisors Upgrades ChargePoint Hldgs to Overweight, Announces $15 Price Target
Fox Advisors analyst Steven Fox upgrades ChargePoint Hldgs (NYSE:CHPT) from Equal-Weight to Overweight and announces $15 price target.
JP Morgan Upgrades Grab Hldgs to Overweight, Lowers Price Target to $3
JP Morgan analyst Ranjan Sharma upgrades Grab Hldgs (NASDAQ:GRAB) from Neutral to Overweight and lowers the price target from $3.5 to $3.
Morgan Stanley Upgrades Houlihan Lokey to Equal-Weight, Lowers Price Target to $82
Morgan Stanley analyst Manan Gosalia upgrades Houlihan Lokey (NYSE:HLI) from Underweight to Equal-Weight and lowers the price target from $95 to $82.
RBC Capital Upgrades Canfor Pulp Products to Outperform, Raises Price Target to C$8
RBC Capital analyst Paul Quinn upgrades Canfor Pulp Products (TSX:CFX) from Sector Perform to Outperform and raises the price target from C$6 to C$8.
Why Stifel Analysts Upgraded These Rail Stocks To A Buy: ‘It Shouldn’t Be As Bad As 2006-2009’
CSX Corporation (NASDAQ: CSX) and Norfolk Southern Corp. (NYSE: NSC) traded higher on Friday after Stifel upgraded the two companies from a Hold rating to a Buy rating.
Edward Jones Upgrades Qualcomm to Buy
Edward Jones analyst Logan Purk upgrades Qualcomm (NASDAQ:QCOM) from Hold to Buy.
Goldman Sachs Upgrades Allogene Therapeutics to Buy, Raises Price Target to $32
Goldman Sachs analyst Salveen Richter upgrades Allogene Therapeutics (NASDAQ:ALLO) from Neutral to Buy and raises the price target from $9 to $32.